Correction: Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

G N Hortobagyi, S M Stemmer, H A Burris, Y S Yap, G S Sonke, S Paluch-Shimon, M Campone, K Petrakova, K L Blackwell, E P Winer, W Janni, S Verma, P Conte, C L Arteaga, D A Cameron, S Mondal, F Su, M Miller, M Elmeliegy, C GermaJ O'Shaughnessy

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalAnnals of Oncology
Early online date13 Aug 2019
DOIs
Publication statusE-pub ahead of print - 13 Aug 2019

Cite this